NASDAQ · MISCELLANEOUS CHEMICAL PRODUCTS
ASP Isotopes Inc. ASPI
4 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$23.8M
▲ 475.5% vs FY2024
EPS · FY25
$-2.11
Dividend / sh · FY25
—
Payout · FY25
-0%
ROE · FY25
-126.8%
Net margin · FY25
-670.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 23.8M
Revenue, FY2025 · full 4-year series below
Revenue
Net income
The company lost 670 cents on every revenue dollar this year.
Per share
USD -2.11
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-126.8%
Return on equity, FY2025
ROE
Operating margin-251.2%
Net margin-670.2%
Return on assets-54.0%
Each USD of equity lost 127 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit-0.0%
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.11B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 498.0M
total assets, end of FY2025
Total assetsUSD 498.0M
EquityUSD 204.2M
CashUSD 285.6M
Gross debtUSD 14.4M
Net debtUSD -271.2M
Current ratio12.23×
The company holds more cash than debt.
History
4 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
Revenue $B
0.0
0.0
0.0
0.0
Operating income $B
−0.1
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
−0.0
0.0
Net income $B
−0.2
−0.0
−0.0
−0.0
EPS, diluted $
−2.11
−0.63
−0.49
·
Dividend / sh $
·
·
·
·
Payout %
−0
−9
−0
·
ROE %
−126.8
−101.0
−124.8
−50.4
Shares out B
0.11
0.07
0.05
0.04
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
14 of 16
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 2 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed